(Reuters) -Life sciences firm Agilent Technologies on Monday beat fourth-quarter revenue estimates, helped by strong demand for medical tools and equipment used in lab research and diagnostic services.

The laboratory equipment maker also forecast revenue for financial year 2026, which started in November, slightly ahead of Wall Street expectations.

Agilent sees 2026 revenue to be between $7.3 billion and $7.4 billion, the midpoint of which is ahead of average analyst estimates of $7.30 billion, according to data compiled by LSEG.

Medical equipment makers have seen renewed demand for contract research and diagnostics services, as pharmaceutical companies accelerate drug development in the U.S. amid President Donald Trump’s shifting trade policies.

The company’s fourth-quarter revenue ca

See Full Page